(VIANEWS) - VirTra (VTSI), Sonic Automotive (SAH), Neurocrine Biosciences (NBIX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. VirTra (VTSI)
35.8% sales growth and 20.03% return on equity
VirTra, Inc. offers force training simulators, firearms simulators, driving simulators, as well as simulators for military, civilian, law enforcement, education, and civil worldwide.
VirTra's sales growth this year is expected to be 14.9% and 20.4% for next year.
Year-on-year quarterly revenue growth declined by 5%, now sitting on 22.36M for the twelve trailing months.
Volume
Today's last reported volume for VirTra is 17617 which is 59.88% below its average volume of 43920.
VirTra's sales growth for the next quarter is 35.8%. The company's growth estimates for the current quarter and the next is a negative 76.2% and 12.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.03%.
Volatility
VirTra's last day, last week, and last month's current intraday variation average was 1.58%, 1.87%, and 1.61%, respectively.
VirTra's highest amplitude of average volatility was 5.22% (day), 4.65% (last week), and 5.24% (last month), respectively.
VirTra's Stock Yearly Top and Bottom Value
VirTra's stock is valued at $5.07 at 01:22 EST, way below its 52-week high of $12.19 and way above its 52-week low of $4.59.
VirTra's Moving Average
VirTra's worth is under its 50-day moving average of $5.35 and way under its 200-day moving average of $6.95.2. Sonic Automotive (SAH)
35.7% sales growth and 40.02% return on equity
Sonic Automotive, Inc. is an American automotive retailer.
Sonic Automotive's sales growth this year is expected to be 29.8% and 9.2% for next year.
Year-on-year quarterly revenue growth grew by 28.7%, now sitting on 13.2B for the twelve trailing months.
Volume
Today's last reported volume for Sonic Automotive is 237826 which is 42.69% below its average volume of 415026.
Sonic Automotive's sales growth for the next quarter is 35.7%. The company's growth estimates for the current quarter and the next is a negative 1.1% and 34.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 40.02%.
Volatility
Sonic Automotive's last day, last week, and last month's current intraday variation average was 0.53%, 1.05%, and 2.20%, respectively.
Sonic Automotive's highest amplitude of average volatility was 4.59% (day), 3.65% (last week), and 4.64% (last month), respectively.
Sonic Automotive's Stock Yearly Top and Bottom Value
Sonic Automotive's stock is valued at $45.30 at 01:22 EST, way below its 52-week high of $58.00 and way above its 52-week low of $38.64.
Sonic Automotive's Moving Average
Sonic Automotive's value is higher than its 50-day moving average of $44.48 and under its 200-day moving average of $48.82.3. Neurocrine Biosciences (NBIX)
19.2% sales growth and 5.5% return on equity
Neurocrine Biosciences, Inc. is a neuropharmaceutical company that focuses on neuroscience. It develops, delivers, and tests treatments for neurological, endocrine, or psychiatric conditions.
Neurocrine Biosciences's sales growth this year is expected to be 21.9% and 16.2% for next year.
Year-on-year quarterly revenue growth grew by 31.3%, now sitting on 1.21B for the twelve trailing months.
Volume
Today's last reported volume for Neurocrine Biosciences is 829160 which is 12.6% above its average volume of 736334.
Neurocrine Biosciences's sales growth for the next quarter is 19.2%. The company's growth estimates for the current quarter and the next is 37.2% and 169.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.5%.
Volatility
Neurocrine Biosciences's last day, last week, and last month's current intraday variation average was 0.58%, 1.43%, and 1.43%, respectively.
Neurocrine Biosciences's highest amplitude of average volatility was 1.53% (day), 2.68% (last week), and 3.23% (last month), respectively.
Neurocrine Biosciences's Stock Yearly Top and Bottom Value
Neurocrine Biosciences's stock is valued at $97.30 at 01:22 EST, under its 52-week high of $108.02 and way above its 52-week low of $71.88.
Neurocrine Biosciences's Moving Average
Neurocrine Biosciences's value is higher than its 50-day moving average of $91.60 and above its 200-day moving average of $90.06.4. American Tower (AMT)
14.2% sales growth and 38.24% return on equity
American Tower is one of the most important global REITs. It's a leader in independent ownership, operator, and developer multitenant telecom real estate. The portfolio includes approximately 181,000 communication sites.
American Tower's sales growth this year is anticipated to be 15.4% and 7% for next year.
Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 8.59B for the twelve trailing months.
Volume
Today's last reported volume for American Tower is 1428010 which is 29.94% below its average volume of 2038400.
American Tower's sales growth for the next quarter is 14.2%. The company's growth estimates for the ongoing quarter and the next is 16.3% and 45.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.24%.
Volatility
American Tower's last day, last week, and last month's current intraday variation average was 3.66%, 2.25%, and 1.81%, respectively.
American Tower's highest amplitude of average volatility was 3.09% (day), 2.86% (last week), and 3.03% (last month), respectively.
American Tower's Stock Yearly Top and Bottom Value
American Tower's stock is valued at $251.80 at 01:22 EST, way under its 52-week high of $303.72 and way above its 52-week low of $197.50.
American Tower's Moving Average
American Tower's value is under its 50-day moving average of $270.76 and below its 200-day moving average of $265.93.5. Northern Trust (NTRS)
12.5% sales growth and 13.64% return on equity
Northern Trust Corporation is a financial holding firm that provides wealth management and asset servicing. It also offers banking solutions to individuals, corporations and families worldwide.
Northern Trust's sales growth this year is anticipated to be 10% and 7.7% for next year.
Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 6.65B for the twelve trailing months.
Volume
Today's last reported volume for Northern Trust is 623884 which is 21.03% below its average volume of 790069.
Northern Trust's sales growth for the next quarter is 12.5%. The company's growth estimates for the current quarter and the next is 16.3% and 14.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.64%.
Volatility
Northern Trust's last day, last week, and last month's current intraday variation average was 4.85%, 2.31%, and 1.89%, respectively.
Northern Trust's highest amplitude of average volatility was 3.69% (day), 2.66% (last week), and 2.49% (last month), respectively.
Northern Trust's Stock Yearly Top and Bottom Value
Northern Trust's stock is valued at $101.61 at 01:22 EST, way under its 52-week high of $135.15 and above its 52-week low of $100.05.
Northern Trust's Moving Average
Northern Trust's value is below its 50-day moving average of $109.73 and way below its 200-day moving average of $115.94.6. Quaker Chemical Corporation (KWR)
10.5% sales growth and 7.53% return on equity
Quaker Chemical Corporation designs, manufactures and markets a variety of formulated specialty chemicals for various industrial and manufacturing uses.
Quaker Chemical Corporation's sales growth this year is anticipated to be 9.7% and 7% for next year.
Year-on-year quarterly revenue growth grew by 10.3%, now sitting on 1.81B for the twelve trailing months.
Volume
Today's last reported volume for Quaker Chemical Corporation is 83108 which is 7.79% above its average volume of 77098.
Quaker Chemical Corporation's sales growth for the next quarter is 10.5%. The company's growth estimates for the present quarter and the next is a negative 40.1% and 19.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.53%.
Volatility
Quaker Chemical Corporation's last day, last week, and last month's current intraday variation average was 3.73%, 2.97%, and 3.18%, respectively.
Quaker Chemical Corporation's highest amplitude of average volatility was 4.38% (day), 4.28% (last week), and 5.12% (last month), respectively.
Quaker Chemical Corporation's Stock Yearly Top and Bottom Value
Quaker Chemical Corporation's stock is valued at $160.70 at 01:22 EST, way under its 52-week high of $276.60 and way higher than its 52-week low of $134.27.
Quaker Chemical Corporation's Moving Average
Quaker Chemical Corporation's value is below its 50-day moving average of $161.00 and way under its 200-day moving average of $211.06.7. Monro (MNRO)
6.6% sales growth and 8.53% return on equity
Monro, Inc. offers automotive undercar repairs, as well as tire sales and service in the United States.
Monro 's sales growth this year is expected to be 20.4% and 4.6% for next year.
Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 1.34B for the twelve trailing months.
Volume
Today's last reported volume for Monro is 236299 which is 43.51% below its average volume of 418374.
Monro 's sales growth for the next quarter is 6.6%. The company's growth estimates for the current quarter and the next is 21.1% and 5.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.53%.
Volatility
Monro 's last day, last week, and last month's current intraday variation average was 0.63%, 1.41%, and 2.96%, respectively.
Monro 's highest amplitude of average volatility was 2.22% (day), 2.47% (last week), and 4.58% (last month), respectively.
Monro 's Stock Yearly Top and Bottom Value
Monro 's stock is valued at $44.71 at 01:22 EST, way under its 52-week high of $65.30 and way higher than its 52-week low of $37.49.
Monro 's Moving Average
Monro 's value is below its 50-day moving average of $45.27 and way under its 200-day moving average of $52.31.8. Mettler (MTD)
6.2% sales growth and 338.69% return on equity
Mettler-Toledo International Inc. produces and supplies precision instruments worldwide.
Mettler's sales growth this year is expected to be 6% and 6% for next year.
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 3.72B for the twelve trailing months.
Volume
Today's last reported volume for Mettler is 107715 which is 17.41% below its average volume of 130431.
Mettler's sales growth is a negative 0% for the ongoing quarter and 6.2% for the next. The company's growth estimates for the ongoing quarter and the next is 7.5% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 338.69%.
Volatility
Mettler's last day, last week, and last month's current intraday variation average was 4.51%, 3.40%, and 2.94%, respectively.
Mettler's highest amplitude of average volatility was 2.76% (day), 2.65% (last week), and 3.12% (last month), respectively.
Mettler's Stock Yearly Top and Bottom Value
Mettler's stock is valued at $1,206.37 at 01:22 EST, way under its 52-week high of $1,714.75 and above its 52-week low of $1,168.31.